• 1
    Burstein D, Velyvis J, Scott KT, Stock KW, Kim YJ, Jamarillo D, et al. Protocol issues for delayed Gd(DTPA2-)-enhanced MRI (dGEMRIC) for clinical evaluation of articular cartilage. Magn Reson Med 2001; 45: 3641.
  • 2
    Adams ME, Brandt KD. Hypertrophic repair of canine articular cartilage in osteoarthritis after anterior cruciate ligament transection. J Rheumatol 1991; 18: 42835.
  • 3
    Liang MH. Pushing the limits of patient-oriented outcome measurements in the search for disease modifying treatments for osteoarthritis. J Rheumatol 2004; 31 Suppl 70: 615.
  • 4
    Brandt KD, Mazzuca SA, Conrozier T, Dacre JE, Peterfy CG, Provvedini D, et al. Which is the best radiographic protocol for a clinical trial of a structure modifying drug in patients with knee osteoarthritis? [review]. J Rheumatol 2002; 29: 130820.
  • 5
    Conrozier T, Mathieu P, Piperno M, Favret H, Colson F, Vignon M, et al. Selection of knee radiographs for trials of structure-modifying drugs in patients with knee osteoarthritis: a prospective, longitudinal study of Lyon schuss knee radiographs with the definition of adequate alignment of the medial tibial plateau. Arthritis Rheum 2005; 52: 14117.
  • 6
    Mazzuca SA, Brandt KD, Dieppe PA, Doherty M, Katz BP, Lane KA. Effect of alignment of the medial tibial plateau and x-ray beam on apparent progression of osteoarthritis in the standing anteroposterior knee radiograph. Arthritis Rheum 2001; 44: 178694.
  • 7
    Conrozier T, Mathieu P, Piperno M, Provvedini D, Taccoen A, Colson F, et al. Lyon schuss radiographic view of the knee: utility of fluoroscopy for the quality of tibial plateau alignment. J Rheumatol 2004; 31: 58490.
  • 8
    Hellio Le Graverand MP, Mazzuca S, Lassere M, Guermazi A, Pickering E, Brandt K, et al. Assessment of the radioanatomic positioning of the osteoarthritic knee in serial radiographs: comparison of three acquisition techniques. Osteoarthritis Cartilage. In press.
  • 9
    Garnero P, Bingham C, Aronstein W, Cohen S, Conaghan P, Cline G, et al. Treatment with risedronate reduced urinary CTX-II, a specific biochemical marker of cartilage type II collagen degradation, in a 24 month study of knee OA [abstract]. Arthritis Rheum 2004; 50 Suppl 9: S656.
  • 10
    Lohmander LS, Brandt KD, Mazzuca SA, Larsson S, Lane KA, Struglics A, et al. Plasma MMP-3 (stromelysin) concentration predicts joint space narrowing in subjects with early knee osteoarthritis. Trans Orthop Res Soc 2005; 30: 1402.
  • 11
    Adams JG, McAlindon T, Dimasi M, Carey J, Eustace S. Contribution of meniscal extrusion and cartilage loss to joint space narrowing in osteoarthritis. Clin Radiol 1999; 54: 5026.